Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 325,260 | 0.3% | 421,229 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 199,255 | 0.2% | 379,537 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 252,574 | 0.2% | 398,236 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 253,876 | 0.2% | 356,410 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 355,365 | 0.3% | 338,044 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 357,945 | 0.3% | 340,566 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 325,606 | 0.3% | 338,296 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 298,320 | 0.2% | 339,660 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 301,182 | 0.2% | 365,974 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 261,908 | 0.1% | 364,500 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 288,295 | 0.2% | 350,865 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 249,196 | 0.2% | 345,411 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 182,659 | 0.1% | 264,879 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 151,986 | 0.1% | 256,500 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 174,832 | 0.1% | 250,743 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 127,956 | 0.1% | 201,085 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 118,080 | 0.1% | 195,116 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 56,982 | 0.0% | 102,019 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 49,077 | 0.0% | 103,725 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 46,624 | 0.0% | 96,508 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 55,110 | 0.1% | 98,450 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 65,961 | 0.1% | 107,979 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 42,766 | 0.0% | 87,584 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 28,424 | 0.0% | 75,698 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 23,656 | 0.0% | 78,779 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 21,208 | 0.0% | 77,052 | 12/31/2013 |